His seven-year term includes five years as liaison for international affairs, in the sixth year he will be chair of the board, and in the seventh year he will serve as president of the society.
The unique program closely resembles the teamwork in clinical settings.
The Alzheimer’s Drug Discovery Foundation’s Goodes Prize supports researchers transforming the field by translating the biology of aging into new therapeutics and diagnostic tools.
Congratulations to Vijaya B. Kolachalama, PhD, Ignaty Leshchiner, PhD, and Weining Lu, MD.
She serves as director of the Barry M. Manuel Center for Continuing Education and was recognized as a leader in the field of academic continuing professional development.
He is part of the second cohort that represents the next generation of leaders, entrepreneurs, researchers, scientists, activists, intellectual provocateurs, authors, and directors who inspire and catalyze us all to a more just and equitable world.
More than 40 percent of football, soccer, ice hockey, and other contact sport participants under age 30 had signs of the degenerative brain disease, including the first American woman soccer player to be diagnosed.
The nominators say, “Dr. Bird is clearly loved by her patients and staff!”
She will complete a project at Ain Shams University in Egypt that aims to exchange knowledge and establish partnerships.
He will join the team of deans in the Student Affairs Office beginning Sept. 1.